Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 05/19/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 292 publications

Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen.

Efficacy and Safety of Edaravone in Amyotrophic Lateral Sclerosis Patients in Indian Population.

The Short and Intensive Rehabilitation (SHAiR) Program Improves Dropped Head Syndrome Caused by Amyotrophic Lateral Sclerosis: A Case Report.

Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer's Disease Patients.

Risdiplam: A Review in Spinal Muscular Atrophy.

Robot-assisted training using hybrid assistive limb ameliorates gait ability in patients with amyotrophic lateral sclerosis.

The combination of autologous mesenchymal stem cell-derived exosomes and neurotrophic factors as an intervention for amyotrophic lateral sclerosis.

A Case Report of Systemic Intoxication Following Onabotulinum Toxin A Injections Into the Salivary Glands in a Patient With Spinal Muscular Atrophy Type 1.

The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Coenzyme Q10 effects in neurological diseases.

Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy.

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy.

Showing 1-12 of 292

Last Updated : 05/19/2022